TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/19/24 16:04 | 11/15/24 | OLPX | Olaplex Holdings, Inc. | DE | Fash | Beauty | Perfumes, Cosmetics & Other T | Bilbrey John P | NY | D | P.m | 135 | 1.75 | 0 | 77 | 13 | 664 | I | |||||||||||||||
8/21/24 16:29 | 8/19/24 | OLPX | Olaplex Holdings, Inc. | DE | Fash | Beauty | Perfumes, Cosmetics & Other T | Bilbrey John P | NY | D | P | 376 | 2.05 | 0 | 183 | 45 | 587 | I | |||||||||||||||
9/18/23 17:16 | 9/15/23 | OLPX | Olaplex Holdings, Inc. | DE | Fash | Beauty | Perfumes, Cosmetics & Other T | Bilbrey John P | CA | D | P | 19 | 2.29 | 0 | 8 | 4 | 201 | I | |||||||||||||||
8/15/23 16:10 | 8/14/23 | OLPX | Olaplex Holdings, Inc. | DE | Fash | Beauty | Perfumes, Cosmetics & Other T | Bilbrey John P | CA | D | P.m | 132 | 2.63 | 0 | 50 | 35 | 193 | I | |||||||||||||||
11/15/22 16:40 | 11/11/22 | ELAN | Elanco Animal Health Inc | Health | Drug | Pharmaceutical Preparations | Bilbrey John P | IN | D | P | 99 | 13.24 | 0 | 8 | 14 | 63 | I | ||||||||||||||||
5/13/22 17:59 | 5/11/22 | ELAN | Elanco Animal Health Inc | Health | Drug | Pharmaceutical Preparations | Bilbrey John P | IN | D | P | 220 | 22.03 | 0 | 10 | 22 | 55 | I |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |